Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hiv-1 immunogen (4 trials)
incomplete freund's adjuvant (3 trials)
neurovax (3 trials)
omega-3 fatty acids (Omacor) (2 trials)
Acquired Immunodeficiency Syndrome (Phase 3)
Communicable Diseases (Phase 3)
HIV Infections (Phase 3)
Infections (Phase 3)
Multiple Sclerosis (Phase 3)
Sclerosis (Phase 3)
Trials (9 total)
Trial APIs (4 total)